Artivion | CRY - Cost Of Sales


Artivion reported $42.85M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Abbott USD 5.94B 642M Jun/2026
Accuray USD 116.17M 14.63M Dec/2024
AngioDynamics USD 37.29M 786K Sep/2025
Artivion USD 42.85M 3.86M Dec/2025
AtriCure USD 34.98M 3.04M Jun/2026
Baxter International USD 1.93B 118M Jun/2026
Becton, Dickinson and Co. USD 2.67B 108M Jun/2026
Boston Scientific USD 1.86B 29M Jun/2026
Edwards Lifesciences USD 392.4M 29.8M Jun/2026
Inogen USD 39.59M 1.27M Sep/2024
Integra LifeSciences USD 188.86M 10.15M Jun/2026
J&J USD 8B 67M Jun/2026
Mesa Laboratories USD 21.92M 1.78M Sep/2024
Orthofix International USD 66.63M 6.4M Dec/2025
Pfizer USD 4.09B 498M Jun/2026
ResMed USD 612.93M 61.26M Jun/2026
Stryker USD 2.26B 106M Jun/2026
Tandem Diabetes Care USD 109.78M 653K Jun/2026
Teleflex USD 238.62M 2.21M Jun/2026
Terumo JPY 133.27B 18.03B Jun/2026
Trinity Biotech USD 7.17M 666K Dec/2025